A Critical Assessment of Vector Control for Dengue Prevention
Recently, the Vaccines to Vaccinate (v2V) initiative was reconfigured into the Partnership for Dengue Control (PDC), a multi-sponsored and independent initiative. This redirection is consistent with the growing consensus among the dengue-prevention community that no single intervention will be sufficient to control dengue disease. The PDC's expectation is that when an effective dengue virus (DENV) vaccine is commercially available, the public health community will continue to rely on vector control because the two strategies complement and enhance one another. Although the concept of integrated intervention for dengue prevention is gaining increasingly broader acceptance, to date, no consensus has been reached regarding the details of how and what combination of approaches can be most effectively implemented to manage disease. To fill that gap, the PDC proposed a three-step process:
- a critical assessment of current vector control tools and those under development,
- outlining a research agenda for determining, in a definitive way, what existing tools work best, and
- determining how to combine the best vector control options, which have systematically been defined in this process, with DENV vaccines.
To address the first step, the PDC convened a meeting of international experts during November 2013 in Washington, DC, to critically assess existing vector control interventions and tools under development.
This journal article published in May 2015 summarizes those deliberations.